緑膿菌による重度感染症<br>Severe Infections Caused by Pseudomonas Aeruginosa (Perspectives on Critical Care Infectious Diseases, 7)

個数:

緑膿菌による重度感染症
Severe Infections Caused by Pseudomonas Aeruginosa (Perspectives on Critical Care Infectious Diseases, 7)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 250 p.
  • 言語 ENG
  • 商品コード 9781402074219
  • DDC分類 616.92

基本説明

Special attention is paid to such topics as the diagnosis of hospital-acquired pneumonia caused by p. aeruginosa, scheduled antibiotic therapy for patients with cystic fibrosis, empiric therapy for febrile neurotropenic patients, and more.

Full Description

Severe Infections Caused by Pseudomonas aeruginosa emphasizes controversies worldwide in the diagnosis, treatment, prevention and pathogenesis of pseudomonas aeruginosa infections. By including both chapters written by European authors and chapters written by North American experts, the reader is ensured of receiving a broad spectrum of opinions on controversial topics. Special attention is paid to such topics as the diagnosis of hospital-acquired pneumonia caused by p. aeruginosa, scheduled antibiotic therapy for patients with cystic fibrosis, empiric therapy for febrile neurotropenic patients, combination vs. single agent antibiotic therapy for severely ill patients, and alternatives to conventional antibiotic therapies.

This excellent overview of our current understanding of pseudomonas aeruginosa pathogenesis will prove useful to clinicians and microbiologists around the globe.

Contents

1. Pseudomonas aeruginosa Infections in Specific Types of Patients and Clinical Settings.- 2. The Spectrum of Pseudomonas aeruginosa Disease.- 3. Hospital-Acquired Pneumonia Caused by Pseudomonas aeruginosa North American Perspective.- 4. Hospital-Acquired Pneumonia Caused by Pseudomonas aeruginosa European Perspective.- 5. Pseudomonas aeruginosa Infections in Individuals With Cystic Fibrosis North American Perspective.- 6. Pseudomonas aeruginosa Infections in Individuals With Cystic Fibrosis European Perspective.- 7. Pseudomonas aeruginosa Infections in Cancer Patients.- 8. Treatment of Serious Pseudomonas aeruginosa Infections North American Perspective.- 9. Treatment of Serious Pseudomonas aeruginosa Infections European Perspective.- 10. Epidemiology and Control of Pseudomonas aeruginosa Infections in the Intensive Care Unit North American Perspective.- 11. Epidemiology and Control of Pseudomonas aeruginosa Infections in the Intensive Care Unit European Perspective.- 12. New Perspectives on Prevention and Management of Pseudomonas aeruginosa Infections.- 13. Molecular Pathogenesis of Acute Pseudomonas aeruginosa Infections.